Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21
Phase 31
Phase 42

Trial Status

Completed4
Other1

Role Distribution

Principal Investigator3
Other Roles2
PI Rate60%

Activity Timeline

Clinical Trials (5)

NCT01609257Phase 1/2Completed
Norovirus Bivalent-Vaccine Efficacy Study
Prevention From Norovirus Infection
PrincipalinvestigatorStart date: 2012-07-16
NCT01085786Phase 4Completed
Sequential and Hybrid Therapies for H Pylori Infection
Helicobacter Pylori Infection
Studydirector
NCT01868373Phase 1Enrolling By Invitation
Defined Fecal Microbiota Transplantation for Clostridium Difficile Diarrhea
Active C. Difficile Colitis
Principalinvestigator
NCT01980095Phase 3Completed
ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
DyspepsiaHelicobacter Pylori Infection
Principalinvestigator

Research Network

Collaboration Network

12 collaborators·25 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Kwok-Hung Lai, PhD

Kaohsiung Veterans General Hospital.

Related
1 trials

Shared therapeutic areas:

Helicobacter Pylori Infection

Worked with same sponsors:

Baylor College of MedicineKaohsiung Medical University+1 more
Collaborated on 1 trial
Similarity Score14%

John J Treanor, MD

University of Rochester

Related
6 trials

Shared therapeutic areas:

Prevention From Norovirus Infection

Worked with same sponsors:

Takeda
Collaborated on 1 trial
Similarity Score14%

Antone R Opekun, PA-C

Baylor College of Medicine

Related
1 trials

Shared therapeutic areas:

Helicobacter Infections

Worked with same sponsors:

Baylor College of MedicineKaohsiung Veterans General Hospital.
Collaborated on 1 trial
Similarity Score14%

Ching-Kuan Liu, MD, PhD

Kaohsiung Medical Univestity

Related
1 trials

Shared therapeutic areas:

Helicobacter Infections

Worked with same sponsors:

Baylor College of MedicineKaohsiung Veterans General Hospital.
Collaborated on 1 trial
Similarity Score14%

Antone R Opekun, MS, PA-C

Baylor College of Medicine

Related
1 trials

Shared therapeutic areas:

Active C. Difficile Colitis

Worked with same sponsors:

Baylor College of MedicineMichael E. DeBakey VA Medical Center
Collaborated on 1 trial
Similarity Score14%

David Bernstein, MD

Cincinatti Children's Hospital

Related
1 trials

Shared therapeutic areas:

Prevention From Norovirus Infection

Worked with same sponsors:

Takeda
Collaborated on 1 trial
Similarity Score14%

PING-I Hsu, MD, PhD

Kaohsiung Veterans General Hospital.

Related
1 trials

Shared therapeutic areas:

Helicobacter Pylori Infection

Worked with same sponsors:

Baylor College of MedicineKaohsiung Medical University+1 more
Collaborated on 1 trial
Similarity Score14%

Robert L Atmar, MD

Children's Hospital Medical Center, Cincinnati

Related
1 trials

Shared therapeutic areas:

Prevention From Norovirus Infection

Worked with same sponsors:

Takeda
Collaborated on 1 trial
Similarity Score14%

G. Marshall Lyon, MD

Emory University

Related
1 trials

Shared therapeutic areas:

Prevention From Norovirus Infection

Worked with same sponsors:

Takeda
Collaborated on 1 trial
Similarity Score14%

Mohamed S Al-Ibrahim, MB, ChB

SNBL Clinical Pharmacology Center

Related
1 trials

Shared therapeutic areas:

Prevention From Norovirus Infection

Worked with same sponsors:

Takeda
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT01609257Phase 1/2PrincipalInvestigator

Norovirus Bivalent-Vaccine Efficacy Study

Prevention From Norovirus Infection
Completed
NCT00656968Phase 4StudyChair

Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection

Helicobacter Infection
Completed
NCT01085786Phase 4StudyDirector

Sequential and Hybrid Therapies for H Pylori Infection

Helicobacter Pylori Infection
Completed
NCT01868373Phase 1PrincipalInvestigator

Defined Fecal Microbiota Transplantation for Clostridium Difficile Diarrhea

Active C. Difficile Colitis
Enrolling By Invitation
NCT01980095Phase 3PrincipalInvestigator

ERADICATE Hp - Treating Helicobacter Pylori With RHB-105

DyspepsiaHelicobacter Pylori Infection
Completed

All 5 trials loaded